Jalali, F. et al. 2015. First Study of the Safety and Tolerability of Allvec-1, a Gene Therapy Vector, in Patients With Advanced Stage IV Malignant Solid Tumors. Reports of Radiotherapy and Oncology. 2, 1 (Jan. 2015), 1–6.